DK1562573T3 - Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling derafInfo
- Publication number
- DK1562573T3 DK1562573T3 DK02786241T DK02786241T DK1562573T3 DK 1562573 T3 DK1562573 T3 DK 1562573T3 DK 02786241 T DK02786241 T DK 02786241T DK 02786241 T DK02786241 T DK 02786241T DK 1562573 T3 DK1562573 T3 DK 1562573T3
- Authority
- DK
- Denmark
- Prior art keywords
- tamsulosin
- preparation
- pharmaceutical pellets
- pellets
- pharmaceutical
- Prior art date
Links
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 title 1
- 239000008188 pellet Substances 0.000 title 1
- 229960002613 tamsulosin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/293,940 US7018658B2 (en) | 2002-11-14 | 2002-11-14 | Pharmaceutical pellets comprising tamsulosin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1562573T3 true DK1562573T3 (da) | 2006-08-21 |
Family
ID=23131212
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02786241T DK1562573T3 (da) | 2002-11-14 | 2002-12-12 | Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf |
DK200300005U DK200300005U3 (da) | 2002-11-14 | 2003-01-08 | Farmaceutiske pellets indeholdende tamsulosin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK200300005U DK200300005U3 (da) | 2002-11-14 | 2003-01-08 | Farmaceutiske pellets indeholdende tamsulosin |
Country Status (23)
Country | Link |
---|---|
US (1) | US7018658B2 (da) |
EP (1) | EP1562573B1 (da) |
JP (1) | JP5405710B2 (da) |
AT (2) | ATE323478T1 (da) |
AU (3) | AU2002351451A1 (da) |
BE (1) | BE1015435A4 (da) |
CA (1) | CA2415840C (da) |
CH (1) | CH696419A5 (da) |
CZ (1) | CZ13341U1 (da) |
DE (2) | DE20219293U1 (da) |
DK (2) | DK1562573T3 (da) |
ES (1) | ES2257589T3 (da) |
FI (1) | FI5842U1 (da) |
FR (1) | FR2847166B1 (da) |
GB (1) | GB2395125B (da) |
HU (1) | HUP0500832A3 (da) |
NL (1) | NL1022151C2 (da) |
NO (1) | NO20052860L (da) |
PL (1) | PL206083B1 (da) |
PT (1) | PT1562573E (da) |
SI (1) | SI21394A2 (da) |
WO (2) | WO2004043449A1 (da) |
ZA (1) | ZA200503696B (da) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
CA2476496C (en) * | 2002-02-21 | 2009-12-15 | Biovail Laboratories Inc. | Controlled release dosage forms |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US7018658B2 (en) * | 2002-11-14 | 2006-03-28 | Synthon Bv | Pharmaceutical pellets comprising tamsulosin |
EP1638537A1 (en) * | 2003-07-01 | 2006-03-29 | KRKA, tovarna zdravil, d.d., Novo mesto | Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20050106253A1 (en) * | 2003-11-13 | 2005-05-19 | Platteeuw Johannes J. | Pharmaceutical pellets comprising tamsulosin |
WO2005053659A1 (en) * | 2003-12-03 | 2005-06-16 | Natco Pharma Limited | An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation |
SI21637A (sl) * | 2003-12-23 | 2005-06-30 | LEK farmacevtska dru�ba d.d. | Farmacevtska oblika z nadzorovanim sproščanjem |
KR100615952B1 (ko) * | 2004-05-27 | 2006-08-28 | 한국화학연구원 | 서방형 약물 전달 시스템 |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
SI1618873T1 (sl) * | 2004-07-14 | 2007-10-31 | Siegfried Generics Int Ag | Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
WO2007017253A1 (de) * | 2005-08-10 | 2007-02-15 | Add Advanced Drug Delivery Technologies Ltd. | Orales präparat mit kontrollierter freisetzung eines benzolsulfonamids |
KR20070021806A (ko) * | 2005-08-19 | 2007-02-23 | (주)아모레퍼시픽 | α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법 |
KR100745515B1 (ko) * | 2006-04-10 | 2007-08-02 | 주식회사 대웅제약 | 염산 탐술로신 함유 서방성 펠렛 및 그의 제조방법 |
WO2007131804A1 (en) * | 2006-05-17 | 2007-11-22 | Synthon B.V. | Tablet composition with a prolonged release of tamsulosin |
US20090004284A1 (en) * | 2007-06-26 | 2009-01-01 | Watson Pharmaceuticals, Inc. | Controlled release tamsulosin hydrochloride formulation |
EP2047847A1 (en) * | 2007-10-12 | 2009-04-15 | KRKA, tovarna zdravil, d.d., Novo mesto | Solid pharmaceutical composition comprising tamsulosin |
EP2217228B1 (en) * | 2007-10-12 | 2012-04-04 | Krka Tovarna Zdravil, D.D., Novo Mesto | Solid pharmaceutical composition comprising tamsulosin |
US20110244033A1 (en) * | 2008-12-09 | 2011-10-06 | Denny Johan Marijn Van Den Heuvel | Tamsulosin pellets for fixed dose combination |
US8465770B2 (en) * | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
EP2456424B1 (en) | 2009-07-22 | 2013-08-28 | Grünenthal GmbH | Oxidation-stabilized tamper-resistant dosage form |
CN103269688A (zh) | 2010-09-02 | 2013-08-28 | 格吕伦塔尔有限公司 | 包含无机盐的抗破碎剂型 |
WO2012110092A1 (en) | 2011-02-17 | 2012-08-23 | Synthon Bv | Tamsulosin derivatives |
KR20140053159A (ko) | 2011-07-29 | 2014-05-07 | 그뤼넨탈 게엠베하 | 즉시 약물 방출을 제공하는 탬퍼-저항성 정제 |
EA201400173A1 (ru) | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
WO2013123965A1 (en) | 2012-02-20 | 2013-08-29 | Synthon Bv | A fixed dose pharmaceutical formulation |
EP2838512B1 (en) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
BR112015024348A2 (pt) | 2013-06-21 | 2017-07-18 | Wockhardt Ltd | composições farmacêuticas de tansulosina ou sais destas |
EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
CA2931553C (en) | 2013-11-26 | 2022-01-18 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
EP2949319A1 (en) | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
CZ2015225A3 (cs) * | 2015-03-30 | 2016-10-12 | Zentiva, K.S. | Nový krok ve způsobu potahování pelet obsahujících Tamsulosin.HCI |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
CN105287395A (zh) * | 2015-11-19 | 2016-02-03 | 哈尔滨圣吉药业股份有限公司 | 一种盐酸坦索罗辛缓释微丸及其制备方法 |
KR102391495B1 (ko) | 2016-03-31 | 2022-04-28 | 한미약품 주식회사 | 안정성 및 용출율이 개선된 타다라필 및 탐수로신 함유 캡슐 복합제제 |
EP3473244A1 (en) | 2017-10-20 | 2019-04-24 | Veru Inc. | Controlled release oral tamsulosin hydrochloride |
EP3473245A1 (en) | 2017-10-20 | 2019-04-24 | Veru Inc. | Controlled release oral tamsulosin hydrochloride |
EP4422599A1 (en) | 2021-10-25 | 2024-09-04 | Farmalider, S.A. | Tadalafil oral suspension |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
JPS61100526A (ja) * | 1984-10-22 | 1986-05-19 | Kyowa Hakko Kogyo Co Ltd | 持続性ドパミン経黒剤 |
US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
IE60311B1 (en) | 1987-09-24 | 1994-06-29 | American Home Prod | Sustained release etodolac |
JPH07316077A (ja) * | 1994-05-20 | 1995-12-05 | Sumitomo Pharmaceut Co Ltd | 腸溶性コーティング用組成物 |
US6177430B1 (en) * | 1997-03-27 | 2001-01-23 | Pfizer Inc | Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
AR023700A1 (es) * | 1998-11-12 | 2002-09-04 | Smithkline Beecham Plc | Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina |
EP1064938A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
JP3154710B1 (ja) * | 1999-08-09 | 2001-04-09 | 山之内製薬株式会社 | 下部尿路症治療剤 |
KR20020016944A (ko) * | 1999-08-09 | 2002-03-06 | 오노다 마사요시 | 하부 요로증 치료용 의약 조성물 |
ATE376414T1 (de) * | 1999-09-02 | 2007-11-15 | Nostrum Pharmaceuticals Inc | Pellet formulierung mit gesteuerter freisetzung |
US6368628B1 (en) | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
US6287599B1 (en) | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
SI1443917T1 (sl) * | 2001-11-07 | 2006-06-30 | Synthon Bv | Tablete tamsulozina |
US7018658B2 (en) * | 2002-11-14 | 2006-03-28 | Synthon Bv | Pharmaceutical pellets comprising tamsulosin |
-
2002
- 2002-11-14 US US10/293,940 patent/US7018658B2/en not_active Expired - Lifetime
- 2002-12-12 DE DE20219293U patent/DE20219293U1/de not_active Ceased
- 2002-12-12 PT PT02786241T patent/PT1562573E/pt unknown
- 2002-12-12 WO PCT/NL2002/000821 patent/WO2004043449A1/en active IP Right Grant
- 2002-12-12 AT AT02786241T patent/ATE323478T1/de active
- 2002-12-12 GB GB0229021A patent/GB2395125B/en not_active Expired - Lifetime
- 2002-12-12 DK DK02786241T patent/DK1562573T3/da active
- 2002-12-12 EP EP02786241A patent/EP1562573B1/en not_active Revoked
- 2002-12-12 HU HU0500832A patent/HUP0500832A3/hu unknown
- 2002-12-12 DE DE60210828T patent/DE60210828T2/de not_active Expired - Lifetime
- 2002-12-12 NL NL1022151A patent/NL1022151C2/nl not_active IP Right Cessation
- 2002-12-12 JP JP2004551288A patent/JP5405710B2/ja not_active Expired - Lifetime
- 2002-12-12 ES ES02786241T patent/ES2257589T3/es not_active Expired - Lifetime
- 2002-12-12 AU AU2002351451A patent/AU2002351451A1/en not_active Abandoned
- 2002-12-16 FI FI20020500U patent/FI5842U1/fi active
- 2002-12-17 CZ CZ200213764U patent/CZ13341U1/cs not_active IP Right Cessation
- 2002-12-18 PL PL357856A patent/PL206083B1/pl unknown
- 2002-12-27 SI SI200200319A patent/SI21394A2/sl unknown
- 2002-12-30 CH CH02222/02A patent/CH696419A5/de not_active IP Right Cessation
-
2003
- 2003-01-02 AT AT0000203U patent/AT6542U1/de not_active IP Right Cessation
- 2003-01-08 DK DK200300005U patent/DK200300005U3/da active
- 2003-01-08 CA CA002415840A patent/CA2415840C/en not_active Expired - Lifetime
- 2003-01-09 AU AU2003200059A patent/AU2003200059B2/en not_active Expired
- 2003-01-22 FR FR0300651A patent/FR2847166B1/fr not_active Expired - Lifetime
- 2003-03-24 BE BE2003/0184A patent/BE1015435A4/nl not_active IP Right Cessation
- 2003-11-13 AU AU2003288083A patent/AU2003288083A1/en not_active Abandoned
- 2003-11-13 WO PCT/EP2003/012829 patent/WO2004043448A1/en not_active Application Discontinuation
-
2005
- 2005-05-09 ZA ZA200503696A patent/ZA200503696B/en unknown
- 2005-06-13 NO NO20052860A patent/NO20052860L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1562573T3 (da) | Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf | |
DK1480622T3 (da) | Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf | |
DK1534237T3 (da) | Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf | |
NO20031776L (no) | Null-boringskomplettering og produksjonssystem | |
NO20055173D0 (no) | Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel | |
IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
IS2504B (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
DK1753406T4 (da) | Overtrukket tabletformulering og fremgangsmåde | |
DK1509266T3 (da) | System omfattende en dyse og et holdersystem | |
DE60210315D1 (de) | Tamsulosin tabletten | |
IS7369A (is) | Aðferð og tæki til örflögunýmyndunar | |
ATE555809T1 (de) | Pharmezeutische anti-tnf-alpha antikörper formulierung | |
IS7715A (is) | Nýjar lyfjasamsetningar úr módafíníl | |
IS7594A (is) | Laxófoxifen tafla og húðun hennar | |
ATE388693T1 (de) | Wohlschmeckende kautablette | |
DK1560826T3 (da) | Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse | |
NO20043333L (no) | Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem | |
IS7266A (is) | Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra | |
NO20042890L (no) | Farmasoytiske preparater og fremgangsmate for fremstilling derav | |
DK1639107T3 (da) | Forbedrede proteaser og fremgangsmåder til fremstilling deraf | |
IS7846A (is) | Aðferð til að framleiða lyfjafræðilega virkt efnasamband og til að framleiða milliefni þess | |
SI1562573T1 (sl) | Farmacevtske pilule, ki vsebujejo tamsulozin in postopek priprave le teh | |
NO20054893D0 (no) | Polymere modifiseringsmidler og farmasoytiske preparater | |
UA5530S (uk) | Таблетка фармацевтична | |
AU156818S (en) | Pharmaceutical tablet |